ClinicalTrials.gg
RecruitingNCT07877935Updated Oct 16, 2026

Testing Interventions to Mitigate the Health Impact of Heatwaves on Primary School Children in Climate-vulnerable Districts of Bangladesh.

An interventional study of Solar reflective paint and Bamboo ceiling with polyethylene foam in Heat Cramps, Heat Rash and Heat Exhaustion, sponsored by BRAC University. Recruiting at 2 sites in Bangladesh. Open to participants aged 7 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by BRAC University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled May 2025, registered Oct 2026).
  • Started May 2025; still recruiting 1 year 5 months later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
2,875
Allocation
Randomized
Ages
7 Years to 14 Years
Sex
All
01

Study summary

The goal of this clinical trial is to assess the impact of implementing a combination of heat education and school-based physical infrastructure interventions in reducing heat related illnesses and improving educational outcomes among primary school children aged 7-14 years in two climate-vulnerable districts of Bangladesh.

The main questions it aims to answer are:

Whether different combinations of heat education and physical infrastructure interventions can reduce indoor classroom temperatures and heat-related illnesses and improve the health and mental well-being of primary school children.

Whether these interventions can improve educational outcomes among primary school children and provide cost-effective and scalable solutions for heat mitigation in low-resource settings.

Researchers will compare different combinations of interventions, including: (1) heat education with solar reflective paint, (2) heat education with bamboo ceiling and polyethylene foam, and (3) heat education with both solar reflective paint and bamboo ceiling with polyethylene foam, to assess their relative cost-effectiveness.

The interventions will be implemented in BRAC Education Programme-run primary schools in Gaibandha and Kurigram districts. Children will be the primary participants of the study. Researchers will assess changes in classroom indoor temperature, heat-related health outcomes and mental well-being among children, as well as their school attendance and academic performance. The study will also explore potential scalability of the interventions in similar settings.

02

Conditions studied

  • Heat Cramps
  • Heat Rash
  • Heat Exhaustion
  • Heat Stress
  • Heat Anxiety

Browse trials for

Keywords

  • Heatwave
  • Education
  • Health
  • Randomized Control Trial (RCT)
03

In context

Heat Stress Disorders

113 studies on the registry are indexed under Heat Stress Disorders; 46 are open to participants now.

This study's planned enrollment of 2,875 is above the median of 24 across 99 interventional studies indexed under Heat Stress Disorders.

Browse Heat Stress Disorders studies →

Lead sponsor

BRAC University is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The inclusion criteria of choosing schools would be: 1) Having tin as roof top, 2) Availability of proper ventilation 3) Thickness of tin to be above 120 millimetres and 4) Structure of the house not fragile. All primary school children (ages 7-14 years) in the selected schools will be considered as the target population.

Exclusion criteria

Exclusion Criteria:

  • We will exclude schools that already have heat mitigation measures and children who have pre-existing health conditions.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,875 participants (estimated)

Study arms

  • Experimental
    Heat education toolkit + solar reflective paint

    Other: Solar reflective paint · Behavioral: Heat education toolkit

  • Experimental
    Heat education toolkit + bamboo ceiling with polyethylene foam

    Other: Bamboo ceiling with polyethylene foam · Behavioral: Heat education toolkit

  • Experimental
    Heat education toolkit + solar reflective paint + bamboo ceiling with polyethylene foam

    Other: Solar reflective paint · Other: Bamboo ceiling with polyethylene foam · Behavioral: Heat education toolkit

  • Experimental
    Heat education toolkit

    Behavioral: Heat education toolkit

  • No intervention
    No Intervention

Interventions

  • OtherSolar reflective paint

    Solar reflective paint is a special type of paint used to lower surface temperature in tin-roofs. It works by generating an obstacle between the sun and the tin-roofs. It has ingredients (colour particles) that are designed to reflect ultraviolet (UV) rays of the sun. When it is used in a tin-roof house, it reduces the impact of direct sunlight on the surface of the tin roof and decrease internal temperature of the house.

  • OtherBamboo ceiling with polyethylene foam

    Bamboo ceiling combined with polyethylene foam will be utilized for thermal insulation in tin-roof houses. Bamboo, known for its natural insulation properties, acts as a barrier between the tin roof and living space, providing passive cooling. Polyethylene foam further prevents heat transfer, enhancing the insulation. The combination of these materials creates a two-layer system, which is hypothesized to be more effective at reducing indoor temperatures than using either material alone.

  • BehavioralHeat education toolkit

    The heat education toolkit will be co-created by the research team with input from students, government and non-government stakeholders, parents, teachers, and healthcare providers. The toolkit will be used in the classrooms to educate students on the negative impacts of heatwaves and how to cope with it. The lessons will be interactive and cover different topics such as what is a heatwave, why heatwaves occur, the effects of heatwaves on the environment and humans, and what can be done to minimize the impacts of heatwaves.

06

What researchers measure

Primary outcomes

  1. Incidence of Heat Rash

    * Case Definition: Inflammatory skin condition caused by blocked sweat glands, commonly occurring in hot and humid conditions. * Diagnostic Criteria: * Red, itchy rash or tiny blisters on chest, back, neck, or other covered areas * Occurs after sweating or prolonged heat exposure * May be described by the child as prickly, itchy, or burning * Outcome Threshold: Presence of a red, itchy rash or blisters in covered areas following heat exposure, as reported by the child or caregiver or observed directly.

    Time frame: April to November each year during 2025-2027

  2. Incidence of Heat Cramps

    * Case Definition: Painful, involuntary muscle spasms caused by salt loss through sweating, typically after physical activity. * Diagnostic Criteria: * Complaints of muscle cramps or spasms in legs, arms, or abdomen * Occurs after physical exertion in a hot environment * Often accompanied by heavy sweating * Outcome Threshold: Reported or observed muscle pain or spasms following activity in hot conditions, in the absence of severe systemic symptoms.

    Time frame: April to November each year during 2025-2027

  3. Incidence of Heat Exhaustion

    * Case Definition: Heat-related illness resulting from water or salt depletion, leading to fatigue and inability to continue activity, without altered mental status. * Diagnostic Criteria: * At least two of the following symptoms: * Weakness or fatigue * Headache * Nausea or vomiting * Dizziness * Muscle cramps * Heavy sweating * No confusion, disorientation, or unconsciousness * Body temperature less than 40°C * Outcome Threshold: Two or more qualifying symptoms after heat exposure, with normal mental status and no high fever (≥40°C), as reported or observed.

    Time frame: April to November each year during 2025-2027

  4. Incidence of Heat stress

    Time frame: April to November each year during 2025-2027

  5. Incidence of Heat Anxiety

    Time frame: April to November each year during 2025-2027

Secondary outcomes

  1. Academic performance

    Time frame: April to January each year during 2025-2028

  2. School absenteeism

    Time frame: April to January each year during 2025-2028

  3. Cases of pneumonia

    Time frame: April to November each year during 2025-2027

  4. Cases of diarrhoea

    Time frame: April to November each year during 2025-2027

07

Study locations

2 of 2 sites recruiting
  • BRAC Schools
    Gaibandha, Rangpur Division, Bangladesh
    Recruiting
  • BRAC Schools
    Kurigram, Rangpur Division, Bangladesh
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified data will be shared with other study team members for joint analysis and publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Jan 2028, 32 months after the start.

Of 69 non-industry interventional studies with no phase under Heat Stress Disorders, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 32 months is above that.

Counting every sponsor, half of 69 studies reached it within 16 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 11, 2026
First posted
Oct 16, 2026
StartActual
May 13, 2025
Primary completionEst.
Jan 31, 2028
CompletionEst.
Dec 2028
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07877935
Lead sponsor
BRAC University
Collaborators
Brac, International Development Research Centre, Canada
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
May 13, 2025
Primary completion
Jan 31, 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Oct 16, 2026

Study contacts

Md Tanvir Hasan Professor, PhD
Contact
thasan@bracu.ac.bd
+880-2-48812213-18 ext. 103

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion